Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term luseogliflozin plus GLP-1 receptor agonist in type 2 diabetes
jRCT1080222532Phase 4
- Sponsor
- Taisho Pharmaceutical
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of luseogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Taisho Pharmaceutical.
02
Drugs
luseogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT1080222532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222532.